Presentation is loading. Please wait.

Presentation is loading. Please wait.

Jacqueline Baras Shreibati et al. JCHF 2017;j.jchf

Published byEustacia Cross Modified over 5 years ago

Similar presentations

Presentation on theme: "Jacqueline Baras Shreibati et al. JCHF 2017;j.jchf"— Presentation transcript:

1 Jacqueline Baras Shreibati et al. JCHF 2017;j.jchf.2016.09.008
Comparison of Model Survival Curves With Registry Data The survival curves for LVAD and medical management are based on INTERMACS and MedaMACS registry data, respectively (12,14). INTERMACS = Interagency for Mechanically Assisted Circulatory Support; LVAD = left ventricular assist device; MedaMACS = Medical Arm of the Mechanically Assisted Circulatory Support. Jacqueline Baras Shreibati et al. JCHF 2017;j.jchf American College of Cardiology Foundation

Download ppt "Jacqueline Baras Shreibati et al. JCHF 2017;j.jchf"

Similar presentations

Date of download: 6/28/2016 Copyright © The American College of Cardiology. All rights reserved. From: The HVAD Left Ventricular Assist Device: Risk Factors.

Date of download: 6/28/2016 Copyright © The American College of Cardiology. All rights reserved. From: The HVAD Left Ventricular Assist Device: Risk Factors.
Date of download: 7/9/2016 Copyright © The American College of Cardiology. All rights reserved. From: Results of the Destination Therapy Post-Food and.

Date of download: 7/9/2016 Copyright © The American College of Cardiology. All rights reserved. From: Results of the Destination Therapy Post-Food and.
Jennifer A. Cowger, MD, Matthew A

Jennifer A. Cowger, MD, Matthew A
Risk scores for predicting mortality after surgical ventricular reconstruction for ischemic cardiomyopathy: Results of a Japanese multicenter study  Satoru.

Risk scores for predicting mortality after surgical ventricular reconstruction for ischemic cardiomyopathy: Results of a Japanese multicenter study  Satoru.
Muhammad Shahreyar et al. JACEP 2016;j.jacep

Muhammad Shahreyar et al. JACEP 2016;j.jacep
Philipp Blanke et al. JIMG 2015;8:

Philipp Blanke et al. JIMG 2015;8:
G. Michael Felker et al. JCHF 2014;2:

G. Michael Felker et al. JCHF 2014;2:
Carolyn Y. Ho et al. JCHF 2015;3:

Carolyn Y. Ho et al. JCHF 2015;3:
Caroline Zotter-Tufaro et al. JCHF 2015;3:

Caroline Zotter-Tufaro et al. JCHF 2015;3:
David S. Frankel et al. JACEP 2015;1:

David S. Frankel et al. JACEP 2015;1:
Belinda Gray et al. JCHF 2013;1:

Belinda Gray et al. JCHF 2013;1:
David F. Katz et al. JACEP 2016;j.jacep

David F. Katz et al. JACEP 2016;j.jacep
Mintu P. Turakhia et al. JACEP 2016;2:

Mintu P. Turakhia et al. JACEP 2016;2:
Long-term mechanical circulatory support (destination therapy): On track to compete with heart transplantation?  James K. Kirklin, MD, David C. Naftel,

Long-term mechanical circulatory support (destination therapy): On track to compete with heart transplantation?  James K. Kirklin, MD, David C. Naftel,
Wayne L. Miller et al. JCHF 2013;1:

Wayne L. Miller et al. JCHF 2013;1:
Giuseppe Boriani et al. JACEP 2016;2:

Giuseppe Boriani et al. JACEP 2016;2:
Mohit K. Turagam et al. JACEP 2017;3:

Mohit K. Turagam et al. JACEP 2017;3:
Federico Migliore et al. JACEP 2016;2:

Federico Migliore et al. JACEP 2016;2:
Prabhat Kumar et al. JACEP 2016;j.jacep

Prabhat Kumar et al. JACEP 2016;j.jacep
Postmarket Experience With HeartMate 3 Left Ventricular Assist Device: 30-Day Outcomes From the ELEVATE Registry  Jens Garbade, MD, PhD, Finn Gustafsson,

Postmarket Experience With HeartMate 3 Left Ventricular Assist Device: 30-Day Outcomes From the ELEVATE Registry  Jens Garbade, MD, PhD, Finn Gustafsson,

Similar presentations

Ads by Google